Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that it has been selected as a finalist in the Diversity, Equity & Inclusion Commitment Category for Ragan's CSR & Diversity Awards Program. This recognition celebrates the outstanding efforts of organizations that have demonstrated exemplary commitment to corporate social responsibility and fostering diversity and inclusion within their communities and workplaces.

The winners of Ragan's CSR & Diversity Awards will be announced during a special industry Awards Luncheon on September 28, 2023, held at the Yale Club in New York City. The event will bring together leading industry professionals, CSR advocates and DE&I champions to celebrate the finalists and their exceptional contributions.

Ragan's CSR & Diversity Awards program honors companies and individuals who have displayed exceptional dedication to making a positive impact on society and promoting diversity in all its forms. Being recognized as a finalist is a testament to Inogen's commitment to driving positive change.

Inogen was chosen from a wide pool of entries to receive recognition as a FINALIST in Ragan’s CSR & Diversity Awards in the Diversity, Equity & Inclusion Commitment category for its FreshAir@Inogen campaign led by their internal Diversity, Equity, Inclusion, Belonging & Accessibility (DEIBA) Taskforce which began in June of 2022.

Highlights of the program include a 50-person volunteer DEIBA Taskforce that established a DEIBA Vision and principles to guide their work as they tackled modernizing benefit plans, improving selection processes, ensuring equitable compensation, a monthly roadmap of internal communications and stories by associates about their experiences and achievements, engagement surveys, mentoring, and both psychological safety and inclusive leader training.

Executive Vice President and Chief Human Resources Officer Jen Yi Boyer shared, “The ways that our associates have embraced this work provide endless proof points celebrating the strength of our culture and desire of our team members to make a difference every single day. Our focus on initiating collaborative dialogue through shared storytelling at all levels of the organization from the board of directors to our front-line teams created a sense of community and belonging leading to measurable improvements in engagement.”

For more information about the Ragan's CSR & Diversity Awards Program 2023 and the upcoming awards luncheon, you can visit the official luncheon page.

About Inogen

Inogen, Inc. (Nasdaq: INGN) is a leading global medical technology company offering innovative respiratory products for use in the homecare setting. Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Inogen partners with patients, prescribers, home medical equipment providers, and distributors to make its oxygen therapy products widely available allowing patients the chance to remain ambulatory while managing the impact of their disease.

For more information, please visit www.inogen.com.

Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.

About Ragan Communications and PR Daily:

Ragan Communications has been delivering trusted news, training, and intelligence for more than 50 years to internal and external communicators and business executives via its conferences, webinars, training, awards, subscriptions and its membership divisions. Its daily news sites—PRDaily.com and Ragan.com — are read by more than 600,000 internal and external communicators monthly.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230808646384/en/